Dr. David Edward Kahler, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Hospital Rd, Coal Township, PA 17866 Phone: 570-644-4229 |
Patrick D Pugliese, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4200 Hospital Rd, Emergency Department, Coal Township, PA 17866 Phone: 570-644-4222 |
Patrick Chabra, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Hospital Rd, Coal Township, PA 17866 Phone: 570-644-4222 Fax: 570-644-4241 |
Michael A. Scicchitano, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Hospital Road, Shamokin Area Community Hospital, Coal Township, PA 17866 Phone: 570-644-4222 |
News Archive
Tumor necrosis factor inhibitors (TNFis) are used to treat inflammatory conditions, such as RA. These agents work by blocking TNF, an important mediator of inflammation in RA, in order to help reduce inflammation and stop disease progression.
After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise.
Roche announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patients from male urine and self -collected vaginal swabs.
More than 36 million people worldwide, including 1.2 million in the U.S., are living with an HIV infection. Today's anti-retroviral cocktails block how HIV replicates, matures and gets into uninfected cells, but they can't eradicate the virus.
RaySearch Laboratories AB has received two new orders for its RayStation treatment planning system. The first order comes from a Canadian cancer care and research facility. They will use RayStation as a research tool for the development of an exciting new treatment machine that combines a traditional linear accelerator with a Magnetic Resonance Imaging scanner.
› Verified 6 days ago